Skin conditions (dermatitis, eczema, psoriasis) Board decisions

The Board remands the Veteran's claims for higher ratings for eczema, residual scars of eczema, hyperkeratosis, right hand palm, and migraines to correct pre-decisional duty to assist errors.

The Board remands the claims for an earlier effective date and initial compensable rating for dermatitis with venereal warts and HSV 2 to obtain a medical opinion on whether the Veteran's use of topical corticosteroids constituted systemic therapy.

The Board denied increased ratings for hypertension, PTSD with MDD and insomnia disorder, tinnitus, right ear hearing loss, eczematous dermatitis of the wrists and feet, and DDD, L5-S1, with retrolisthesis. TDIU was granted as of September 22, 2015.

The Board granted service connection for tinea unguium and denied the claims for service connection for a right shoulder disability, a dental disability (tooth #8) for compensation purposes, as well as effective dates earlier than April 6, 2023, for the grant of service connection for sinusitis, rhinitis, GERD, and PTSD. The Board also denied compensable ratings for sinusitis, a rating in excess of 10 percent for rhinitis, a rating in excess of 10 percent for GERD, and a rating in excess of 50 percent for PTSD.

The Board remands the veteran's claims for increased ratings and service connection due to a need for additional evidence and examinations.

The Board granted service connection for a skin condition, other than contact dermatitis, to include dyshidrotic eczema and acne, based on the evidence showing that these conditions were at least as likely as not incurred during active service.

The Board denied service connection for a traumatic brain injury (TBI) and remanded claims for service connection for left knee, right knee, left shoulder, right shoulder, right hip, headaches, persistent depressive disorder, and pseudofolliculitis barbae.

The appeal was dismissed due to the Veteran's passing in December 2023.

The appeal was dismissed because the Board of Veterans' Appeals determined that there is no longer a case or controversy regarding entitlement to service connection for cystic acne, as it has already been awarded.

The Veteran is granted a total disability rating for compensation purposes based on individual unemployability due to service-connected disabilities and basic eligibility for Dependents' Educational Assistance benefits.

The Board denied the veteran's claims for increased initial disability ratings and effective dates, as well as remanded a claim for entitlement to TDIU.

The veteran withdrew all pending claims and appeals, resulting in the dismissal of the appeal.

The Board denied service connection for visual impairment and remanded the claims for cervical strain, eczema, and lumbosacral strain.

The Board granted an initial rating of 10 percent for dermatitis, effective January 8, 2025.

The appeal for service connection for sleep apnea was dismissed due to untimeliness, while the claims for a skin disability and stomach disability were remanded for further examination.

The Veteran's eczema with a history of atopic dermatitis is rated as 60 percent disabling, and he has been granted a total disability rating based on individual unemployability due to his service-connected disabilities.

The Board remands the claims for further development due to pre-decisional duty to assist errors, including unconfirmed service locations and lack of VA examinations.

The Board granted service connection for an acquired psychiatric disorder and a respiratory condition, but denied service connection for chloracne. The Veteran's bladder cancer was rated at the maximum schedular rating of 100 percent, and an earlier effective date for DEA benefits was also denied.

The Board granted service connection for tinea pedis and bilateral foot arthritis, but denied service connection for diabetes mellitus type II. For the increase rating period from July 22, 2022, a maximum 60 percent rating for tinea versicolor was granted.

The Board dismissed the appeals for service connection and increased rating due to improper concurrent election of review options.